Discovery and Validation of a Compound to Target Ewing’s Sarcoma

Ewing’s sarcoma, characterized by pathognomonic t (11; 22) (q24; q12) and related chromosomal ETS family translocations, is a rare aggressive cancer of bone and soft tissue. Current protocols that include cytotoxic chemotherapeutic agents effectively treat localized disease; however, these aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Esfandiari Nazzaro, Ellie, Sabei, Fahad Y., Vogel, Walter K., Nazari, Mohamad, Nicholson, Katelyn S., Gafken, Philip R., Taratula, Olena, Taratula, Oleh, Davare, Monika A., Leid, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538197/
https://www.ncbi.nlm.nih.gov/pubmed/34683845
http://dx.doi.org/10.3390/pharmaceutics13101553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538197/
https://www.ncbi.nlm.nih.gov/pubmed/34683845
http://dx.doi.org/10.3390/pharmaceutics13101553

Ejemplares similares